Pacifica Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7K | Sell |
230
-30
| -12% | -$1.39K | ﹤0.01% | 330 |
|
|
2025
Q1 | $15K | Hold |
260
| – | – | 0.01% | 303 |
|
|
2024
Q4 | $14.8K | Sell |
260
-560
| -68% | -$31.8K | 0.01% | 312 |
|
|
2024
Q3 | $42.4K | Sell |
820
-145
| -15% | -$7.5K | 0.02% | 219 |
|
|
2024
Q2 | $38.6K | Sell |
965
-62,672
| -98% | -$2.51M | 0.02% | 232 |
|
|
2024
Q1 | $3.32M | Sell |
63,637
-658
| -1% | -$34.3K | 1.47% | 25 |
|
|
2023
Q4 | $3.23M | Sell |
64,295
-399
| -0.6% | -$20K | 1.59% | 19 |
|
|
2023
Q3 | $3.65M | Sell |
64,694
-199
| -0.3% | -$11.2K | 1.99% | 14 |
|
|
2023
Q2 | $4.2M | Buy |
64,893
+6,816
| +12% | +$441K | 2.38% | 11 |
|
|
2023
Q1 | $4.09M | Buy |
58,077
+10,476
| +22% | +$738K | 2.46% | 8 |
|
|
2022
Q4 | $3.46M | Buy |
47,601
+6,120
| +15% | +$445K | 2.35% | 11 |
|
|
2022
Q3 | $2.73M | Sell |
41,481
-550
| -1% | -$36.2K | 1.98% | 14 |
|
|
2022
Q2 | $3.36M | Sell |
42,031
-694
| -2% | -$55.5K | 2.32% | 9 |
|
|
2022
Q1 | $2.94M | Sell |
42,725
-3,743
| -8% | -$257K | 1.91% | 13 |
|
|
2021
Q4 | $2.92M | Buy |
46,468
+766
| +2% | +$48.1K | 1.91% | 14 |
|
|
2021
Q3 | $2.75M | Buy |
45,702
+1,646
| +4% | +$99K | 2% | 14 |
|
|
2021
Q2 | $2.92M | Buy |
44,056
+1,335
| +3% | +$88.3K | 2.21% | 11 |
|
|
2021
Q1 | $2.68M | Buy |
42,721
+4,916
| +13% | +$309K | 2.21% | 11 |
|
|
2020
Q4 | $2.31M | Buy |
+37,805
| New | +$2.31M | 2.23% | 11 |
|